-
srdr.ahrq.gov/projects/1312/studies/133267
January 01, 2015 - Comments ( 0 ) |
Post/View
n Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 hours
N Analyzed … .74
1.76
SE
2 hours
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133270
January 01, 2011 - Comments ( 0 ) |
Post/View
n Analyzed … All Participants
Time Point
Measure
Control 1
Exposure 1
0 hours
N Analyzed … SE
.6
.5
6 hours
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133339
January 01, 2013 - Comments ( 0 ) |
Post/View
n Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 hours
N Analyzed … .39
.3
SE
24 hours
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/188522
January 01, 2019 - No CPAP
Enter a numeric value or title (required) years
N Analyzed
1030 … No CPAP
Enter a numeric value or title (required) years
N Analyzed
1030 … No CPAP
Enter a numeric value or title (required) years
N Analyzed
1030 … No CPAP
Enter a numeric value or title (required) years
N Analyzed
1030
-
srdr.ahrq.gov/projects/1565/studies/189285
January 01, 2018 - Point
Measure
No active treatment
MAD
Moderate OSA
Severe OSA
Baseline N/A
N Analyzed … 29.5
26
32.1
6 months
N Analyzed … Point
Measure
No active treatment
MAD
Moderate OSA
Severe OSA
Baseline N/A
N Analyzed … 0.2
0.2
0.3
6 months
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133119
January 01, 2012 - Comments ( 0 ) |
Post/View
n Analyzed … All Participants
Time Point
Measure
Exposure 1
Control 1
0 minutes
N Analyzed … Mean
SD
SE
120 minutes
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133148
January 01, 2008 - Comments ( 0 ) |
Post/View
n Analyzed … Measure
Exposure 1
Control 1
Exposure 2
Exposure 3
Control 2
0 hours
N Analyzed … 3.6
4.8
SE
2 hours
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133243
January 01, 2013 - Comments ( 0 ) |
Post/View
n Analyzed … Time Point
Measure
Exposure 1
Exposure 2
Control 1
Exposure 3
0 days
N Analyzed … .71
.42
SE
6 days
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133242
January 01, 2008 - Comments ( 0 ) |
Post/View
n Analyzed … Participants
Time Point
Measure
Exposure 1
Exposure 2
Control 1
0 hours
N Analyzed … .3
.3
SE
2 hours
N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/147777
January 01, 2016 - Comments ( 0 ) |
Post/View
n Analyzed … Exposure 1
Exposure 2
Exposure 3
Exposure 4
Exposure 5
Control 1
0 hours
N Analyzed … 1.4
SE
8 hours
N Analyzed
-
srdr.ahrq.gov/projects/1542/studies/186860
January 01, 1998 - Triptans: None (before or during pregnancy)
Not reported N/A
N Analyzed … Triptans: None (before or during pregnancy)
Delivery N/A
N Analyzed
82 … Triptans: None (before or during pregnancy)
Delivery N/A
N Analyzed
82 … Triptans: None (before or during pregnancy)
Delivery N/A
N Analyzed
82 … Triptans: None (before or during pregnancy)
Delivery N/A
N Analyzed
96
-
srdr.ahrq.gov/projects/1520/studies/186803
January 01, 2017 - Placebo
48 weeks
N Analyzed
165
168
P-Value
0.226 … Placebo
48 weeks
N Analyzed
165
168
Hazard Ratio (HR)
0.60 … Population: All Participants
Time Point
Measure
Pharm: 5-ASA (3.0 g/d)
Placebo
48 weeks
N Analyzed … Population: All Participants
Time Point
Measure
Pharm: 5-ASA (3.0 g/d)
Placebo
48 weeks
N Analyzed … Population: All Participants
Time Point
Measure
Pharm: 5-ASA (3.0 g/d)
Placebo
48 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/188640
January 01, 2014 - No CPAP
82 months
N Analyzed
441
268 … No CPAP
82 months
N Analyzed
314
184 … No CPAP
82 months
N Analyzed
127
84 … No CPAP
82 months
N Analyzed
441
268 … No CPAP
82 months
N Analyzed
441
268
-
srdr.ahrq.gov/projects/1520/studies/186801
January 01, 2007 - Measure
No intervention (non-placebo)
Antibiotics: Cephalosporin + Metronidazole
Baseline N/A
N Analyzed … Measure
No intervention (non-placebo)
Antibiotics: Cephalosporin + Metronidazole
Baseline N/A
N Analyzed … Counts
78
34
Percentage
51
41
1-4 weeks
N Analyzed … 83
Counts
52
33
Percentage
34
40
>4 weeks
N Analyzed … Measure
No intervention (non-placebo)
Antibiotics: Cephalosporin + Metronidazole
Baseline N/A
N Analyzed
-
srdr.ahrq.gov/projects/1542/studies/186834
January 01, 2011 - Triptans: Almotriptan
Triptans: Eletriptan
Antihistamines: Pizotifen
Delivery N/A
N Analyzed … Triptans: Almotriptan
Triptans: Eletriptan
Antihistamines: Pizotifen
Delivery N/A
N Analyzed … Triptans: Almotriptan
Triptans: Eletriptan
Antihistamines: Pizotifen
Delivery N/A
N Analyzed … Triptans: Almotriptan
Triptans: Eletriptan
Antihistamines: Pizotifen
Delivery N/A
N Analyzed … Triptans: Almotriptan
Triptans: Eletriptan
Antihistamines: Pizotifen
<37 weeks
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186804
January 01, 2017 - Placebo
48 weeks
N Analyzed
87
75
81
P-Value … episode
Time Point
Measure
Pharm: 5-ASA (1.5 g/d)
Pharm: 5-ASA (3.0 g/d)
Placebo
48 weeks
N Analyzed … episode
Time Point
Measure
Pharm: 5-ASA (1.5 g/d)
Pharm: 5-ASA (3.0 g/d)
Placebo
48 weeks
N Analyzed … 18
27
Percentage
35
48.6
56.3
96 weeks
N Analyzed … Placebo
48 weeks
N Analyzed
87
75
81
Hazard Ratio (HR)
-
srdr.ahrq.gov/projects/1520/studies/186826
January 01, 2016 - Participants
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … years old
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … years old
Time Point
Measure
Colonoscopy
Enter a numeric value or title (required) years
N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186831
January 01, 2014 - Time Point
Measure
Colonoscopy
No Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Time Point
Measure
Colonoscopy
No Colonoscopy
Enter a numeric value or title (required) years
N Analyzed … Time Point
Measure
Colonoscopy
No Colonoscopy
Enter a numeric value or title (required) years
N Analyzed
-
srdr.ahrq.gov/projects/1565/studies/188644
January 01, 2018 - No CPAP
≤3 years
N Analyzed
70,469
184,112 … ERROR
≤3 years
N Analyzed
NR
NR
Interaction … ERROR
≤3 years
N Analyzed
NR
NR
Interaction … ERROR
≤3 years
N Analyzed
NR
NR
Interaction
-
srdr.ahrq.gov/projects/1520/studies/186725
January 01, 2016 - Elective surgery
30 days
N Analyzed
1660
2452
2973
3130 … Elective surgery
N/A N/A
N Analyzed
1660
2452
2973
3130 … Elective surgery
N/A N/A
N Analyzed
1660
2452
2973
3130 … Elective surgery
N/A N/A
N Analyzed
1660
2452
2973
3130 … Elective surgery
N/A N/A
N Analyzed
1660
2452
2973
3130